
Fiserv reported weak third-quarter 2026 results, including a 29.17% drop in nine-month free cash flow and a $6.45 billion goodwill impairment causing a large GAAP loss without cash impact. Despite 9% growth in Clover payment volume, revenue rose only 1%, highlighting concerns about converting volume growth into revenue. The company’s expanded $1 billion Elevate savings plan aims to support margin recovery, but sustained improvement depends on execution and renewed free cash flow growth. Fiserv kept its guidance unchanged, signaling cautious optimism amid challenges.
Fiserv's stock shows resilience despite the challenging results, trading slightly down by 1.31% on Pluang. The share price stands at USD 55.88 with a market cap of $29.73 billion. These figures are current as of Nov 21, 2026 21:01 WIB.